399 related articles for article (PubMed ID: 15026345)
1. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.
Kridel SJ; Axelrod F; Rozenkrantz N; Smith JW
Cancer Res; 2004 Mar; 64(6):2070-5. PubMed ID: 15026345
[TBL] [Abstract][Full Text] [Related]
2. Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2014 Jan; 1840(1):294-302. PubMed ID: 24060750
[TBL] [Abstract][Full Text] [Related]
3. Development of a Self-Assembled Nanoparticle Formulation of Orlistat, Nano-ORL, with Increased Cytotoxicity against Human Tumor Cell Lines.
Hill TK; Davis AL; Wheeler FB; Kelkar SS; Freund EC; Lowther WT; Kridel SJ; Mohs AM
Mol Pharm; 2016 Mar; 13(3):720-8. PubMed ID: 26824142
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.
Kant S; Kumar A; Singh SM
Biochim Biophys Acta; 2012 Nov; 1820(11):1764-73. PubMed ID: 22877747
[TBL] [Abstract][Full Text] [Related]
5. The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.
Seguin F; Carvalho MA; Bastos DC; Agostini M; Zecchin KG; Alvarez-Flores MP; Chudzinski-Tavassi AM; Coletta RD; Graner E
Br J Cancer; 2012 Sep; 107(6):977-87. PubMed ID: 22892389
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo.
Dowling S; Cox J; Cenedella RJ
Lipids; 2009 Jun; 44(6):489-98. PubMed ID: 19381703
[TBL] [Abstract][Full Text] [Related]
7. Metabolic shifts induced by fatty acid synthase inhibitor orlistat in non-small cell lung carcinoma cells provide novel pharmacodynamic biomarkers for positron emission tomography and magnetic resonance spectroscopy.
Sankaranarayanapillai M; Zhang N; Baggerly KA; Gelovani JG
Mol Imaging Biol; 2013 Apr; 15(2):136-47. PubMed ID: 22886728
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.
Brusselmans K; De Schrijver E; Heyns W; Verhoeven G; Swinnen JV
Int J Cancer; 2003 Oct; 106(6):856-62. PubMed ID: 12918062
[TBL] [Abstract][Full Text] [Related]
9. A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.
Zhu M; Harshbarger WD; Robles O; Krysiak J; Hull KG; Cho SW; Richardson RD; Yang Y; Garcia A; Spiegelman L; Ramirez B; Wilson CT; Yau JA; Moore JT; Walker CB; Sacchettini JC; Liu WR; Sieber SA; Smith JW; Romo D
Bioorg Med Chem; 2017 Jun; 25(11):2901-2916. PubMed ID: 28236510
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel beta-lactone inhibitors of fatty acid synthase.
Richardson RD; Ma G; Oyola Y; Zancanella M; Knowles LM; Cieplak P; Romo D; Smith JW
J Med Chem; 2008 Sep; 51(17):5285-96. PubMed ID: 18710210
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
Yoshii Y; Furukawa T; Oyama N; Hasegawa Y; Kiyono Y; Nishii R; Waki A; Tsuji AB; Sogawa C; Wakizaka H; Fukumura T; Yoshii H; Fujibayashi Y; Lewis JS; Saga T
PLoS One; 2013; 8(5):e64570. PubMed ID: 23741342
[TBL] [Abstract][Full Text] [Related]
12. Effects of Fatty Acid Synthase Inhibition by Orlistat on Proliferation of Endometrial Cancer Cell Lines.
Wysham WZ; Roque DR; Han J; Zhang L; Guo H; Gehrig PA; Zhou C; Bae-Jump VL
Target Oncol; 2016 Dec; 11(6):763-769. PubMed ID: 27188391
[TBL] [Abstract][Full Text] [Related]
13. Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Schcolnik-Cabrera A; Chávez-Blanco A; Domínguez-Gómez G; Taja-Chayeb L; Morales-Barcenas R; Trejo-Becerril C; Perez-Cardenas E; Gonzalez-Fierro A; Dueñas-González A
Expert Opin Investig Drugs; 2018 May; 27(5):475-489. PubMed ID: 29723075
[TBL] [Abstract][Full Text] [Related]
14. A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2.
Knowles LM; Axelrod F; Browne CD; Smith JW
J Biol Chem; 2004 Jul; 279(29):30540-5. PubMed ID: 15138278
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.
Carvalho MA; Zecchin KG; Seguin F; Bastos DC; Agostini M; Rangel AL; Veiga SS; Raposo HF; Oliveira HC; Loda M; Coletta RD; Graner E
Int J Cancer; 2008 Dec; 123(11):2557-65. PubMed ID: 18770866
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat.
Pemble CW; Johnson LC; Kridel SJ; Lowther WT
Nat Struct Mol Biol; 2007 Aug; 14(8):704-9. PubMed ID: 17618296
[TBL] [Abstract][Full Text] [Related]
17. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells.
Wright C; Iyer AKV; Kaushik V; Azad N
J Cell Biochem; 2017 Nov; 118(11):3834-3845. PubMed ID: 28387458
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.
Ross J; Najjar AM; Sankaranarayanapillai M; Tong WP; Kaluarachchi K; Ronen SM
Mol Cancer Ther; 2008 Aug; 7(8):2556-65. PubMed ID: 18723500
[TBL] [Abstract][Full Text] [Related]
19. Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities.
Yang PY; Liu K; Ngai MH; Lear MJ; Wenk MR; Yao SQ
J Am Chem Soc; 2010 Jan; 132(2):656-66. PubMed ID: 20028024
[TBL] [Abstract][Full Text] [Related]
20. Orlistat Reduces Proliferation and Enhances Apoptosis in Human Pancreatic Cancer Cells (PANC-1).
Sokolowska E; Presler M; Goyke E; Milczarek R; Swierczynski J; Sledzinski T
Anticancer Res; 2017 Nov; 37(11):6321-6327. PubMed ID: 29061815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
